Phase 4 Pancreatitis Trial, Recruiting NCT07083063 Sponsor: National Cheng-Kung University Hospital Condition: Pancreatitis
Back to Pancreatitis

Phase 4 Pancreatitis Trial, Recruiting

NCT07083063
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You are having a procedure called ERCP (a scope procedure) with a small cut to remove a stone from your bile duct (a tube that carries digestive fluid from your liver)

Who may not be able to join:

  • You have been diagnosed with pancreatic cancer
  • You are in shock, meaning your blood pressure is very low (below 90 mmHg on the top number) or you need certain medicines to keep your blood pressure up
  • You have had an allergic reaction to a medicine called nitroglycerin (NTG)
  • You have a type of eye condition called angle-closure glaucoma (confirm with trial site)
  • You have been told you have severe anemia (very low red blood cell levels)
  • You are currently taking medicines known as PDE 5 inhibitors, such as sildenafil (Viagra) or similar drugs used for erectile dysfunction or pulmonary hypertension

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +88662353535

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
National Cheng-Kung University Hospital
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
31 July 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Occurrence of Post-ERCP pancreatitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov